As of 2025-08-06, the EV/EBITDA ratio of Eone Diagnomics Genome Center Co Ltd (245620.KQ) is -4.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 245620.KQ's latest enterprise value is 107,061.15 mil KRW. 245620.KQ's TTM EBITDA according to its financial statements is -23,494.02 mil KRW. Dividing these 2 quantities gives us the above 245620.KQ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.6x | 10.6x |
| Forward P/E multiples | 8.4x - 10.7x | 9.5x |
| Fair Price | (1,888.25) - (2,169.86) | (2,067.22) |
| Upside | -555.0% - -622.9% | -598.1% |
| Date | EV/EBITDA |